Allergen Immuno Therapy Labs Private Limited - Company Profile

It is a business services private limited company based in Bangalore South, Karnataka, India, established in 2025.
2025 Bangalore South, Karnataka, India Active
Last Updated:
Access Report
About Allergen Immuno Therapy Labs Private Limited

Allergen Immuno Therapy Labs Private Limited, a active private limited company, was established on 30 January 2025 in Bangalore South, Karnataka, India. it holds CIN: U86100KA2025PTC197521. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sudha Nagendra Komarla (Director), Nagendra Prasad Komarla Venugopal (Director), Puneet Komarla Nagendra (Director). It is based at No. 55, 2Nd Cross, Gavipuram Extension,, Opp Kohinoor Playground, Bangalore South, Karnataka, 560019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U86100KA2025PTC197521

  • Registration Number

    197521

  • Incorporation Date

    30 January 2025

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 24 Days
Company report

Allergen Immuno Therapy Labs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Allergen Immuno Therapy Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Allergen Immuno Therapy Labs Private Limited?
Current Directors
Name Designation Appointment Date Status
Sudha Nagendra Komarla Director 30 Jan 2025 Current
Nagendra Prasad Komarla Venugopal Director 30 Jan 2025 Current
Puneet Komarla Nagendra Director 30 Jan 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Allergen Immuno Therapy Labs.
Allergen Immuno Therapy Labs revenue growth over time
Allergen Immuno Therapy Labs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Allergen Immuno Therapy Labs?

Unlock access to Allergen Immuno Therapy Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Allergen Immuno Therapy Labs?

Unlock and access historical data on people associated with Allergen Immuno Therapy Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Allergen Immuno Therapy Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allergen Immuno Therapy Labs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Allergen Immuno Therapy Labs
Recent Activity within the Organization
  • Director Appointment

    Sudha Nagendra Komarla was appointed as a Director was appointed as a Director on 30 Jan 2025 & has been associated with this company since 1 year 24 days . was recorded as a recent event.

  • Director Appointment

    Progress on Nagendra Prasad Komarla Venugopal was appointed as a Director was appointed as a Director on 30 Jan 2025 & has been associated with this company since 1 year 24 days . was documented.

  • Director Appointment

    Progress on Puneet Komarla Nagendra was appointed as a Director was appointed as a Director on 30 Jan 2025 & has been associated with this company since 1 year 24 days . was documented.

  • Company Incorporation

    Allergen Immuno Therapy Labs Private Limited was registered on 30 Jan 2025 with Roc Bangalore & aged 1 year 24 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Allergen Immuno Therapy Labs Private Limited?

The CIN of Allergen Immuno Therapy Labs Private Limited is U86100KA2025PTC197521.

Where is Allergen Immuno Therapy Labs Private Limited headquartered?

Allergen Immuno Therapy Labs Private Limited is headquartered at No. 55, 2Nd Cross, Gavipuram Extension,, Opp Kohinoor Playground, Bangalore South, Karnataka, 560019.

When was Allergen Immuno Therapy Labs Private Limited incorporated?

Allergen Immuno Therapy Labs Private Limited was incorporated on 30 January 2025.

Who are the current directors of Allergen Immuno Therapy Labs Private Limited?

The current directors of Allergen Immuno Therapy Labs Private Limited are

Is Allergen Immuno Therapy Labs Private Limited a listed company?

Allergen Immuno Therapy Labs Private Limited is unlisted.

What is the capital structure of Allergen Immuno Therapy Labs Private Limited?

The authorized capital of Allergen Immuno Therapy Labs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available